Soren Skovlund
Novo Nordisk's Søren Skovlund Speaks to Pharma IQ about Best Practice Approaches to Patient Education and Self-Management
June 23 by Soren SkovlundSøren Skovlund is director of global patient research, advocacy and support in Novo Nordisk and oversees the global DAWN (Diabetes Attitudes Wishes & Needs) study led by Novo Nordisk. In...